Nov 10,2020

Carbon Health raises $100 million with plans to expand pop-up clinics ahead of COVID-19 vaccination programs

Carbon Health has raised a $100 million Series C funding round, led by Dragoneer Investment Group and including participation from prior investors Brookfield Technology Partners, DCVC and Builders VC. This funding will be used to help the SF-based healthcare provider startup continue to expand its nationwide footprint, including with the opening of 100 pop-up clinics planned for 20 markets across the U.S.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Nov 20,2020

Voluntis Successfully Completes a Capital Increase of €5.9 Million and Finalizes the Financing of Its Strategic Roadmap

Voluntis announces today the completion of a capital increase without preferential subscription rights exclusively reserved to the category of investors defined below for a total amount of €5.9 million. The securities were subscribed by quality European investors, most of them specialized in the healthcare sector, including Debiopharm Innovation Fund, Corporate fund of Swiss company Debiopharm, and Indigo, the holding company of M. Eric Carreel, Chairman & co-founder of Withings, which strengthened its position.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Nov 30,2020

Habitual Health secures £325k Seed investment led by Seedcamp

Habitual, the UK’s first fully digital diabetes prevention and reversal programme, has today announced a raise of £325,000 in funding, taking its total to £575,000, to support its public launch in 2021.

FUNDING PRE SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Jan 18,2021

Senseonics Holdings Announces $50.0 Million Bought Deal Offering of Common Stock

Senseonics Holdings today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co. under which the underwriter has agreed to purchase on a firm commitment basis 25,974,026 shares of common stock of the Company at a public offering price of $1.925 per shareThe gross proceeds of the offering are expected to be approximately $50.0 million, prior to deducting underwriting discounts and commissions and estimated offering expenses and excluding the exercise of the underwriter’s option to purchase additional shares.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Jan 27,2021

DARIOHEALTH ANNOUNCES ACQUISITION OF LEADING DIGITAL MUSCULOSKELETAL COMPANY UPRIGHT TECHNOLOGIES AND $70 MILLION FINANCING

DarioHealth Corp. announced today the signing of a definitive agreement to acquire digital musculoskeletal (MSK) company Upright Technologies Ltd. in a stock transaction. Dario has concurrently announced definitive agreements with a syndicate of highly regarded healthcare institutional investors to raise $70 million through a private placement of its common stock priced at the market pursuant to Nasdaq rules. Dario has executed securities purchase agreements for the sale of an aggregate of 3,278,688 shares of its common stock at a purchase price of $21.35 per share. Dario intends to use the net proceeds from the offering for general corporate purposes.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Feb 11,2021

Nemaura Medical Secures $20 Million Non-Dilutive Non-convertible Loan to Accelerate Growth

Nemaura Medical, Inc., a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces it has secured a $20 million non-dilutive, non-convertible loan that was secured by Company assets. The loan does not include warrants or other equity securities. Nemaura Medical CEO, Dr. Faz Chowdhury said, “We appreciate the continued strong support from our lender, Chicago Venture Partners.”

FUNDING POST-IPO DEBT
View Analyst & Ambassador Comments
Go to original news
Feb 11,2021

Diabetes treatment start-up funding round takes total capital to £3.6m

UK-based digital health start-up Quin has just closed its latest fundraising round, placing its total capital raised to date at £3.6 million. The Quin app provides personalised diabetes treatment information for people who take insulin to manage their blood glucose levels.

FUNDING SEED
View Analyst & Ambassador Comments
Go to original news
Feb 25,2021

January AI raises $8.8 million for AI that helps people manage their diabetes

January AI, a startup developing a platform that predicts diabetic patients’ responses to certain foods, today announced that it raised $8.8 million. Notable investors in the round included Salesforce CEO Marc Benioff, YouTube cofounder Steve Chen, and former Yahoo! CEO Marissa Mayer.

FUNDING VENTURE ROUND
View Analyst & Ambassador Comments
Go to original news
Mar 16,2021

Glooko Raises $30 Million Financing Round

Glooko Inc., a leading provider of remote patient monitoring and chronic care management solutions including diabetes and obesity has raised a $30 million Series D round of funding. The financing was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic. Proceeds will be used to accelerate organic growth and strategic initiatives across the company’s broad and growing product line of advanced digital health solutions.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Apr 13,2021

CeQur Raises $115 Million Series C5 Financing to Support Commercialization and Scale-Up of Automated Manufacturing for CeQur Simplicity Wearable Insulin-Delivery Device

CeQur, a medical device company committed to simplifying the lives of people with diabetes by revolutionizing insulin-delivery solutions, today announced the close of an oversubscribed $115 million equity financing. The company will use the funds to advance commercial plans for CeQur Simplicity™, including market development activities, a phased commercial launch strategy that includes a limited market release in 2021, and the scale-up of high-volume manufacturing. CeQur Simplicity is both FDA cleared and CE-marked.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING